Sukhanov et al. demonstrated that the use of SGLT2-Is reduced the expression of NLRP3 in smooth muscle cells expressing SGLT2 proteins and mRNA, reducing oxidative stress and the progression of aortic atherosclerosis under normal glycemic conditions [69]. The gene discussed is SLC5A2; the disease is aortic atherosclerosis.